BNTX and MRNA also getting whacked. This Pfizer news, while headline worthy, isn’t my biggest concern. My thinking is B will have a much wider range of application if all the testing goes as we believe. For me, and others my think differently, who and how or if we partner with is where my concerns are. This space has plenty of room. No one company will monopolize the space. Other big pharma aren’t going to sit back and let Pfizer own the space. B will certainly on the table for other BP. Maybe with more urgency after today.